Showing results (1511-1520 of 1,791) with videos related to

Sort By:
Pageof 180
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 2011
The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancerGunter von Minckwitz, Sibylle Loibl, Christian Jackisch, et al.
The Journal of Biological Chemistry|June 16, 2005
The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunitMamta H Buch, Adam Pickard, Antonio Rodriguez, et al.
Circulation. Arrhythmia and Electrophysiology|December 9, 2020
Heart Size Corrected Electrical Dyssynchrony and Its Impact on Sex-Specific Response to Cardiac Resynchronization TherapyOdette A E Salden, Antonius M W van Stipdonk, Hester M den Ruijter, et al.
Wiener Medizinische Wochenschrift (1946)|January 14, 2021
Involvement of medical students in a surgery congress: impact on learning motivation, decision-making for a career in surgery, and educational curriculumIbrahim Alkatout, Veronika Günther, Sandra Brügge, et al.
Nucleic Acids Research|June 24, 2017
Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteinsNicole J Yang, Monique J Kauke, Fangdi Sun, et al.
Neuron|February 18, 2021
Visualizing a joint future of neuroscience and neuromorphic engineeringFriedemann Zenke, Sander M Bohté, Claudia Clopath, et al.
Oncotarget|April 18, 2018
ADAM17 inhibition enhances platinum efficiency in ovarian cancerNina Hedemann, Christoph Rogmans, Susanne Sebens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyBernd Gerber, Gunter von Minckwitz, Heinrich Stehle, et al.
Journal of Cellular Physiology|August 28, 2009
Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathwayMacarena S Arrázola, Lorena Varela-Nallar, Marcela Colombres, et al.
Pageof 180